CorMedix Inc. (CRMD) Earnings History
Annual and quarterly earnings data from 2008 to 2025
Loading earnings history...
CRMD EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
CRMD Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 88.5% | 48.2% | 52.3% |
| 2024 | 92.7% | -51.4% | -41.2% |
| 2023 | - | - | - |
| 2022 | 94.3% | -46819.9% | -45409.9% |
| 2021 | 22.0% | -15417.5% | -14774.7% |
Download Data
Export CRMD earnings history in CSV or JSON format
Free sign-in required to download data
CorMedix Inc. (CRMD) Earnings Overview
As of May 8, 2026, CorMedix Inc. (CRMD) reported trailing twelve-month net income of $163M, reflecting +780.0% year-over-year growth. The company earned $1.74 per diluted share over the past four quarters, with a net profit margin of 52.3%.
Looking at the long-term picture, CRMD's historical earnings data spans multiple years. The company achieved its highest annual net income of $163M in fiscal 2025, representing a new all-time high.
CorMedix Inc. maintains industry-leading profitability with a gross margin of 88.5%, operating margin of 48.2%, and net margin of 52.3%. This margin structure demonstrates strong pricing power and operational efficiency. View revenue history →
Compared to peers including NKTR (-$164M net income, -297.1% margin), HALO ($317M net income, 22.7% margin), PRAX (-$327M net income), CRMD has outperformed on profitability metrics. Compare CRMD vs NKTR →
CRMD Earnings vs Peers
Earnings metrics vs comparable public companies
CRMD Historical Earnings Data (2008–2025)
18 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $163M | +1009.4% | $150M | $2.04 | 52.3% | 48.2% |
| 2024 | -$18M | +61.3% | -$22M | $-0.30 | -41.2% | -51.4% |
| 2023 | -$46M | -56.0% | -$49M | $-0.91 | - | - |
| 2022 | -$30M | -5.3% | -$31M | $-0.74 | -45409.9% | -46819.9% |
| 2021 | -$28M | -28.1% | -$29M | $-0.75 | -14774.7% | -15417.5% |
| 2020 | -$22M | -34.0% | -$27M | $-0.77 | -9207.7% | -11378.4% |
| 2019 | -$16M | +38.8% | -$21M | $-0.68 | -5801.3% | -7416.3% |
| 2018 | -$27M | +18.7% | -$27M | $-1.51 | -6242.4% | -6250.4% |
| 2017 | -$33M | -33.9% | -$33M | $-2.99 | -10023.4% | -9997.4% |
| 2016 | -$25M | -35.5% | -$25M | $-3.25 | -10996.5% | -11048.8% |
See CRMD's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CRMD Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CRMD vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonCRMD — Frequently Asked Questions
Quick answers to the most common questions about buying CRMD stock.
Is CRMD growing earnings?
CRMD EPS is $1.74, with earnings growth accelerating to +780.0%. This exceeds the 5-year CAGR of N/A. TTM net income reached $163M.
What are CRMD's profit margins?
CorMedix Inc. net margin is +52.3%, with operating margin at +48.2%. Above-average margins indicate pricing power.
How consistent are CRMD's earnings?
CRMD earnings data spans 2008-2025. The accelerating earnings trend is +780.0% YoY. Historical data enables comparison across business cycles.